70 related articles for article (PubMed ID: 7518165)
21. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.
Robert-Guroff M; Popovic M; Gartner S; Markham P; Gallo RC; Reitz MS
J Virol; 1990 Jul; 64(7):3391-8. PubMed ID: 2191150
[TBL] [Abstract][Full Text] [Related]
22. Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs.
Swanson AK; Stoltzfus CM
J Biol Chem; 1998 Dec; 273(51):34551-7. PubMed ID: 9852125
[TBL] [Abstract][Full Text] [Related]
23. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.
Schwartz S; Felber BK; Benko DM; Fenyö EM; Pavlakis GN
J Virol; 1990 Jun; 64(6):2519-29. PubMed ID: 2335812
[TBL] [Abstract][Full Text] [Related]
24. Glomerulosclerosis and viral gene expression in HIV-transgenic mice: role of nef.
Kajiyama W; Kopp JB; Marinos NJ; Klotman PE; Dickie P
Kidney Int; 2000 Sep; 58(3):1148-59. PubMed ID: 10972678
[TBL] [Abstract][Full Text] [Related]
25. Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals.
Furtado MR; Kingsley LA; Wolinsky SM
J Virol; 1995 Apr; 69(4):2092-2100. PubMed ID: 7884855
[TBL] [Abstract][Full Text] [Related]
26. Quantitative and discriminative detection of individual HIV-1 mRNA subspecies by an RNAse mapping assay.
Mary C; Telles JN; Cheynet V; Oriol G; Mallet F; Mandrand B; Verrier B
J Virol Methods; 1994 Aug; 49(1):9-23. PubMed ID: 7829596
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes.
Klotman ME; Kim S; Buchbinder A; DeRossi A; Baltimore D; Wong-Staal F
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):5011-5. PubMed ID: 1711215
[TBL] [Abstract][Full Text] [Related]
28. Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells.
Guatelli JC; Gingeras TR; Richman DD
J Virol; 1990 Sep; 64(9):4093-8. PubMed ID: 2384914
[TBL] [Abstract][Full Text] [Related]
29. Analysis of human immunodeficiency virus type 1 mRNA splicing patterns during disease progression in peripheral blood mononuclear cells from infected individuals.
Saltarelli MJ; Hadziyannis E; Hart CE; Harrison JV; Felber BK; Spira TJ; Pavlakis GN
AIDS Res Hum Retroviruses; 1996 Oct; 12(15):1443-56. PubMed ID: 8893052
[TBL] [Abstract][Full Text] [Related]
30. Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort.
Michael NL; Mo T; Merzouki A; O'Shaughnessy M; Oster C; Burke DS; Redfield RR; Birx DL; Cassol SA
J Virol; 1995 Mar; 69(3):1868-77. PubMed ID: 7853528
[TBL] [Abstract][Full Text] [Related]
31. Characterization of murine Dhx32.
Alli Z; Ho M; Ackerley C; Abdelhaleem M
Exp Mol Pathol; 2007 Aug; 83(1):115-8. PubMed ID: 17239371
[TBL] [Abstract][Full Text] [Related]
32. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction.
Reid W; Sadowska M; Denaro F; Rao S; Foulke J; Hayes N; Jones O; Doodnauth D; Davis H; Sill A; O'Driscoll P; Huso D; Fouts T; Lewis G; Hill M; Kamin-Lewis R; Wei C; Ray P; Gallo RC; Reitz M; Bryant J
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9271-6. PubMed ID: 11481487
[TBL] [Abstract][Full Text] [Related]
33. Dynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencing.
Ocwieja KE; Sherrill-Mix S; Mukherjee R; Custers-Allen R; David P; Brown M; Wang S; Link DR; Olson J; Travers K; Schadt E; Bushman FD
Nucleic Acids Res; 2012 Nov; 40(20):10345-55. PubMed ID: 22923523
[TBL] [Abstract][Full Text] [Related]
34. Expression of N-acetylglucosaminyltransferase V mRNA in mammalian tissues and cell lines.
Perng GS; Shoreibah M; Margitich I; Pierce M; Fregien N
Glycobiology; 1994 Dec; 4(6):867-71. PubMed ID: 7734849
[TBL] [Abstract][Full Text] [Related]
35. The induction of cataracts by HIV-1 in transgenic mice.
Iwakura Y; Shioda T; Tosu M; Yoshida E; Hayashi M; Nagata T; Shibuta H
AIDS; 1992 Oct; 6(10):1069-75. PubMed ID: 1466838
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous disorders and viral gene expression in HIV-1 transgenic mice.
Kopp JB; Rooney JF; Wohlenberg C; Dorfman N; Marinos NJ; Bryant JL; Katz SI; Notkins AL; Klotman PE
AIDS Res Hum Retroviruses; 1993 Mar; 9(3):267-75. PubMed ID: 8471318
[TBL] [Abstract][Full Text] [Related]
37. Compensation for a gene trap mutation in the murine microtubule-associated protein 4 locus by alternative polyadenylation and alternative splicing.
Voss AK; Thomas T; Gruss P
Dev Dyn; 1998 Jun; 212(2):258-66. PubMed ID: 9626500
[TBL] [Abstract][Full Text] [Related]
38. B cell lymphoma in HIV transgenic mice.
Curreli S; Krishnan S; Reitz M; Lunardi-Iskandar Y; Lafferty MK; Garzino-Demo A; Zella D; Gallo RC; Bryant J
Retrovirology; 2013 Aug; 10():92. PubMed ID: 23985023
[TBL] [Abstract][Full Text] [Related]
39. A genetic locus regulates the expression of tissue-specific mRNAs from multiple transcription units.
Levy DE; Lerner RA; Wilson MC
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5823-7. PubMed ID: 6310547
[TBL] [Abstract][Full Text] [Related]
40. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
Amendt BA; Si ZH; Stoltzfus CM
Mol Cell Biol; 1995 Nov; 15(11):6480. PubMed ID: 7565800
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
